P S Cohen

826 total citations
14 papers, 719 citations indexed

About

P S Cohen is a scholar working on Molecular Biology, Hematology and Neurology. According to data from OpenAlex, P S Cohen has authored 14 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Neurology. Recurrent topics in P S Cohen's work include Neuroblastoma Research and Treatments (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). P S Cohen is often cited by papers focused on Neuroblastoma Research and Treatments (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). P S Cohen collaborates with scholars based in United States, Germany and Switzerland. P S Cohen's co-authors include Mark A. Israel, Lee J. Helman, Carol J. Thiele, Anthony Cerami, Kevin J. Tracey, Marina Bianchi, David V. Cohn, Mark J. Cooper, Michael A. Levine and A. C. Allison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

P S Cohen

14 papers receiving 705 citations

Peers

P S Cohen
Eric Chan China
Rafael B. Blasco Spain
Shailaja Akunuru United States
Margaret E. Martin United States
Craig B. Thompson United States
S.A. Whitmore Australia
Yoshihiro Horii Japan
Yuan-Yuan Ho Hong Kong
Michael Broman United States
Fumihiko Tanioka Japan
Eric Chan China
P S Cohen
Citations per year, relative to P S Cohen P S Cohen (= 1×) peers Eric Chan

Countries citing papers authored by P S Cohen

Since Specialization
Citations

This map shows the geographic impact of P S Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P S Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P S Cohen more than expected).

Fields of papers citing papers by P S Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P S Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P S Cohen. The network helps show where P S Cohen may publish in the future.

Co-authorship network of co-authors of P S Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of P S Cohen. A scholar is included among the top collaborators of P S Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P S Cohen. P S Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fletcher, Christopher D.�M., et al.. (2007). KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance. Oncogene. 26(44). 6386–6395. 43 indexed citations
2.
Millward, Michael, Colin M. House, David D.L. Bowtell, et al.. (2006). The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study. British Journal of Cancer. 95(7). 829–834. 46 indexed citations
3.
Reichardt, Peter, Daniel Pink, Tobias Lindner, et al.. (2005). A phase I/II trial of the oral PKC-inhibitor PKC412 (PKC) in combination with imatinib mesylate (IM) in patients (pts) with gastrointestinal stromal tumor (GIST) refractory to IM. Journal of Clinical Oncology. 23(16_suppl). 3016–3016. 28 indexed citations
4.
5.
Heidel, Florian H., Frank Breitenbuecher, Thomas Kindler, et al.. (2004). Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML.. Blood. 104(11). 454–454. 6 indexed citations
6.
Bianchi, Marina, Ona Bloom, Tobias Raabe, et al.. (1996). Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone.. The Journal of Experimental Medicine. 183(3). 927–936. 109 indexed citations
7.
Cohen, P S, Harikrishna Nakshatri, Jameel Dennis, et al.. (1996). CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency.. Proceedings of the National Academy of Sciences. 93(9). 3967–3971. 83 indexed citations
8.
Helman, Lee J., P S Cohen, Steven D. Averbuch, et al.. (1989). Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma.. Journal of Clinical Oncology. 7(11). 1720–1725. 55 indexed citations
9.
Cohen, P S, et al.. (1989). Basic molecular biology for the pediatric hematologist/oncologist.. PubMed. 11(4). 467–80. 2 indexed citations
10.
Helman, Lee J., et al.. (1988). Chromogranin A expression in normal and malignant human tissues.. Journal of Clinical Investigation. 82(2). 686–690. 34 indexed citations
11.
Cohen, P S, Robert C. Seeger, Timothy J. Triche, & Mark A. Israel. (1988). Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization.. PubMed. 131(3). 391–7. 37 indexed citations
12.
Thiele, Carol J., P S Cohen, & Mark A. Israel. (1988). Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation.. Molecular and Cellular Biology. 8(4). 1677–1683. 73 indexed citations
13.
Helman, Lee J., Michael A. Levine, A. C. Allison, et al.. (1988). Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA.. Journal of Biological Chemistry. 263(23). 11559–11563. 140 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Chan Breakdown of academic impact, for papers by Rafael B. Blasco Breakdown of academic impact, for papers by Shailaja Akunuru Breakdown of academic impact, for papers by Margaret E. Martin Breakdown of academic impact, for papers by Craig B. Thompson Breakdown of academic impact, for papers by S.A. Whitmore Breakdown of academic impact, for papers by Yoshihiro Horii Breakdown of academic impact, for papers by Yuan-Yuan Ho Breakdown of academic impact, for papers by Michael Broman Breakdown of academic impact, for papers by Fumihiko Tanioka
Rankless by CCL
2026